In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity-Reference-Cited by-同舟云学术

In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity

Published:2016-06-28 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Sainan,Wu Liwei,Feng Jiao,Li Jingjing,Liu Tong,Zhang Rong,Xu Shizan,Cheng Keran,Zhou Yuqing,Zhou Shunfeng,Kong Rui,Chen Kan,Wang Fan,Xia Yujing,Lu Jie,Zhou Yingqun,Dai Weiqi,Guo Chuanyong

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep28479.pdf

Reference85 articles.

1. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, N.Y.) 324, 1029–1033, doi: 10.1126/science.1160809 (2009).

2. Brahimi-Horn, M. C., Chiche, J. & Pouyssegur, J. Hypoxia signalling controls metabolic demand. Current opinion in cell biology 19, 223–229, doi: 10.1016/j.ceb.2007.02.003 (2007).

3. Warburg, O. On the origin of cancer cells. Science (New York, N.Y.) 123, 309–314 (1956).

4. Pouyssegur, J., Dayan, F. & Mazure, N. M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437–443, doi: 10.1038/nature04871 (2006).

5. Fischer, K. et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109, 3812–3819, doi: 10.1182/blood-2006-07-035972 (2007).

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts;Pharmaceuticals;2024-06-06

2. Suppression of androgen receptor and activation of apoptotic signaling pathway in the prostate cancer LNCaP cells: The synergistic effect of Epigallocatechin-3-gallate and conditioned medium derived from WJ-MSCs;2024-04-17

3. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets;Molecules;2024-03-20

4. Hydrogel design to overcome thermal resistance and ROS detoxification in photothermal and photodynamic therapy of cancer;Journal of Controlled Release;2024-02

5. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy;Frontiers in Immunology;2024-01-29